| Not Yet Recruiting | Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesic NCT07515066 | Huan Ye | Phase 1 |
| Not Yet Recruiting | Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis NCT07447102 | Dragonboat Biopharmaceutical Company Limited | Phase 2 |
| Not Yet Recruiting | Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With I NCT07284602 | PureTech | Phase 3 |
| Recruiting | AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF NCT07194382 | Avalyn Pharma Inc. | Phase 2 |
| Recruiting | Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial NCT07482917 | Hospital de Granollers | N/A |
| Recruiting | Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial NCT07486206 | Hospital de Granollers | N/A |
| Not Yet Recruiting | Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy NCT07359963 | Regend Therapeutics | EARLY_Phase 1 |
| Recruiting | A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis NCT06968845 | Rein Therapeutics | Phase 2 |
| Not Yet Recruiting | CAR-DC for End-Stage IPF NCT07329959 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 |
| Recruiting | Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. NCT07466420 | Katerina M. Antoniou | N/A |
| Recruiting | A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of I NCT07464912 | Beijing Tide Pharmaceutical Co., Ltd | Phase 3 |
| Recruiting | A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonar NCT07344558 | Mannkind Corporation | Phase 1 |
| Recruiting | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patient NCT07121413 | Shanghai Synvida Biotechnology Co.,Ltd. | Phase 2 |
| Not Yet Recruiting | Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF NCT07082842 | Sunshine Lake Pharma Co., Ltd. | Phase 3 |
| Not Yet Recruiting | Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary Fibrosis NCT07179562 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Not Yet Recruiting | Disease-syndrome Characteristics of IPF NCT07178392 | Henan University of Traditional Chinese Medicine | — |
| Recruiting | A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patie NCT07332117 | Royal Brompton & Harefield NHS Foundation Trust | — |
| Not Yet Recruiting | Idiopathic Pulmonary Fibrosis Cohort of TCM NCT07162870 | Henan University of Traditional Chinese Medicine | — |
| Not Yet Recruiting | Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fib NCT07131150 | Ruijin Hospital | Phase 2 |
| Completed | The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmo NCT07119099 | Marmara University | — |
| Not Yet Recruiting | Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF NCT06914713 | Henan University of Traditional Chinese Medicine | N/A |
| Not Yet Recruiting | Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF) NCT07019090 | Haisco Pharmaceutical Group Co., Ltd. | Phase 2 |
| Recruiting | Downhill Walking in IPF NCT06756230 | Saglik Bilimleri Universitesi | N/A |
| Not Yet Recruiting | Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study NCT06922916 | Zhejiang University | — |
| Recruiting | An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) NCT06951217 | Avalyn Pharma Inc. | Phase 2 |
| Recruiting | SB17170 Phase 2 Trial in IPF Patients NCT06747923 | SPARK Biopharma | Phase 2 |
| Recruiting | Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomogr NCT07174102 | Azienda Unita Sanitaria Locale di Piacenza | — |
| Completed | PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF NCT06683612 | Contineum Therapeutics | Phase 1 |
| Recruiting | A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. NCT06588686 | Vicore Pharma AB | Phase 2 |
| Active Not Recruiting | Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD NCT06636487 | Copenhagen University Hospital, Hvidovre | N/A |
| Recruiting | D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis NCT06909409 | University of Aarhus | — |
| Completed | Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis NCT06650774 | Karadeniz Technical University | — |
| Recruiting | Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis NCT05975983 | InSilico Medicine Hong Kong Limited | Phase 2 |
| Completed | Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF) NCT05938920 | InSilico Medicine Hong Kong Limited | Phase 2 |
| Completed | Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis NCT07178197 | Mersin University | — |
| Unknown | Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis NCT05387785 | Angion Biomedica Corp | Phase 1 |
| Withdrawn | Inhaled NAC in Treatment of IPF NCT03720483 | University of Colorado, Denver | Phase 1 / Phase 2 |
| Completed | Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） NCT05119972 | Guangdong Raynovent Biotech Co., Ltd | Phase 1 / Phase 2 |
| Active Not Recruiting | Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis NCT04598919 | National Jewish Health | Phase 1 / Phase 2 |
| Terminated | TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis NCT04589260 | Theravance Biopharma | Phase 1 |
| Unknown | Morphine for Dyspnea in Pulmonary Fibrosis NCT04497831 | Medical University of Gdansk | Phase 3 |
| Completed | A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327 NCT04069143 | Bristol-Myers Squibb | Phase 1 |
| Completed | A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants NCT03981094 | Bristol-Myers Squibb | Phase 1 |
| Completed | To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers NCT03650075 | Metagone Biotech Inc. | Phase 1 |
| Completed | A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) NCT03832946 | Galecto Biotech AB | Phase 2 |
| Completed | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy NCT03619616 | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | The Genetics of Pulmonary Fibrosis NCT03478553 | University of Colorado, Denver | — |
| Completed | Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial NCT02874989 | Wake Forest University Health Sciences | Phase 1 |
| Completed | Short-term Effects of Supplemental Oxygen in Patients With IPF NCT03050255 | Schön Klinik Berchtesgadener Land | N/A |
| Completed | Pulmonary Fibrosis Foundation Patient Registry NCT02758808 | Pulmonary Fibrosis Foundation | — |
| Completed | A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibr NCT02538536 | Liminal BioSciences Ltd. | Phase 2 |
| Terminated | Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER) NCT02013700 | Joshua M Hare | Phase 1 |
| Completed | Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis NCT01718990 | University of California, San Francisco | — |
| Recruiting | Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies NCT01776398 | Weill Medical College of Cornell University | — |
| Completed | STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) NCT01371305 | Biogen | Phase 2 |
| Completed | Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide NCT00162760 | Johns Hopkins University | Phase 2 |